Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...
A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University has ...
The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...
A new class of engineered extracellular vesicles induces antigen-specific regulatory T cells, offering a targeted strategy ...
Activation of certain memory B cells may be driving systemic lupus erythematosus incidence in individuals who had ...
Data from a new mouse model may help advance therapeutic development in celiac disease, including improved TG2 inhibitors and ...
Two recent studies show the novel therapy works in people with multiple myeloma, but researchers are trying to minimize side ...
Adaptive Biotechnologies (ADPT) announced two non-exclusive agreements with Pfizer (PFE) to leverage Adaptive’s proprietary T-cell receptor ...
A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritisA data licensing agreement to access ...
A common virus carried by most humans could trigger lupus, offering new clues for preventing and treating this dangerous ...
Research presented December 8 at the American Society of Hematology Conference in Florida, has shown that a new kind of CAR T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results